日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis

通过多组学方法鉴定的CCL14,可作为淋巴管肌瘤病疾病严重程度和进展的新型指标。

Bai, Wenxue; Hua, Lijuan; Wang, Xuezhao; Guo, Mengyao; Chen, Lirong; Liu, Bingyi; Wang, Yi; Zhou, Ying; Wang, Qi; Zhang, Ni; Xie, Min

Efficacy of hybrid blood purification for SA-AKI subtypes identified by CCL14: study protocol for a single-centre randomized controlled clinical trial

混合血液净化治疗CCL14识别的SA-AKI亚型的疗效:单中心随机对照临床试验研究方案

Shi, Keran; Jiang, Wei; Song, Lin; Li, Xianghui; Wang, Jing; Zhao, Renyan; Wang, Haixia; Sun, Fan; Wang, Ran; Pu, Cenlu; Zhang, Chuanqing; Li, Luanluan; Feng, Yunfan; Yu, Jiangquan; Zheng, Ruiqiang

Correction: Long non-coding RNA CCL14-AS suppresses invasiveness and lymph node metastasis of colorectal cancer cells by regulating MEP1A

更正:长链非编码RNA CCL14-AS通过调控MEP1A抑制结直肠癌细胞的侵袭性和淋巴结转移。

Li, Mingzhou; Huang, Chengmei; Wu, Yuanyuan; Zhu, Lina; Zhang, Yaxin; Zhou, Yi; Li, Huali; Liu, Zhihao; Pan, Xinyan; Wang, Xin; Qiu, Junfeng; Li, Fengtian; Liao, Wenting

Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis

趋化因子配体 14 与胃癌微环境中免疫细胞浸润相关,可预测不良预后

Bing Lu #, Jiawen Shi #, Tong Cheng, Congshuo Wang, Manyu Xu, Pingping Sun, Xiaojing Zhang, Lei Yang, Peng Li, Han Wu, Xiaoling Kuai

The chemokine CCL14 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma

趋化因子CCL14是与肺腺癌中免疫细胞浸润相关的潜在生物标志物

Sun, Bai-Er; Yuan, Zai-Xin; Wang, Meng-Jiao; Xu, Li-Qin; Feng, Jian; Chen, Jing-Jing

CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury

CCL14 可预测中重度急性肾损伤患者的少尿和透析需求

Demirjian, Sevag; Chawla, Lakhmir; Davison, Danielle; Forni, Lui G; Heung, Michael; Hoste, Eric A J; Koyner, Jay; Kampf, J Patrick; Kwan, Thomas; McPherson, Paul; Kellum, John A

Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)

探索预测持续性严重急性肾损伤的生物标志物的成本效益:以 CC 基序趋化因子配体 14 (CCL14) 为例

Echeverri, Jorge; Martins, Rui; Harenski, Kai; Kampf, J Patrick; McPherson, Paul; Textoris, Julien; Koyner, Jay L

Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury

尿液CC基序趋化因子配体14(CCL14)标准化临床检测在持续性重度急性肾损伤中的应用性能

Koyner, Jay L; Chawla, Lakhmir S; Bihorac, Azra; Gunnerson, Kyle J; Schroeder, Rebecca; Demirjian, Sevag; Hodgson, Luke; Frey, Jennifer A; Wilber, Scott T; Kampf, J Patrick; Kwan, Thomas; McPherson, Paul; Kellum, John A

Towards a Better Crystal Ball: Urinary C-C Motif Chemokine Ligand 14 (CCL14) and Persistent Severe AKI

展望更准确的预测:尿液CC基序趋化因子配体14 (CCL14)与持续性重度急性肾损伤

Belcher, Justin M

CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis

CCL14通过调节细胞周期和促进细胞凋亡,发挥着肝细胞癌新型预后因子和肿瘤抑制因子的作用。

Zhu, Mengxuan; Xu, Weiyue; Wei, Chuanyuan; Huang, Jing; Xu, Jietian; Zhang, Yuye; Zhao, Yan; Chen, Jie; Dong, Shuangshuang; Liu, Binbin; Liang, Chunmin